Haha nice.
I see Milford are trumpeting a Morningstar award 2/3rds of the way down the following page. Maybe they are losing their touch.
http://milfordasset.com/investing/pr...alth/overview/
Printable View
Haha nice.
I see Milford are trumpeting a Morningstar award 2/3rds of the way down the following page. Maybe they are losing their touch.
http://milfordasset.com/investing/pr...alth/overview/
“A cynic is a man who knows the price of everything, and the value of nothing.”
– Oscar Wilde
One buy order for 600000 @ 69c this morning. Could be an interesting day.
There seems to be a freeze, anyone else seeing this?
Just as a general response from a new boy on the thread to suggestions that the science behind ATM is suspect: If that is so, why aren't we seeing the mainstream industry (including Fonterra) with its huge global research resources actually disputing it with scientific fact and argument? Why have we not seen any scientific rebuttal of Woodford's book and subsequent blog reports, which are based on scores of peer-reviewed studies? It would be totally in the industry's interest to rebut the A1-A2 milk thesis IF IT COULD, because the unavoidable implication of it is that most of the world's cows-milk supply which contains the A1 beta-casein poses a health threat.
The only attempt at a rebuttal that I'm aware of was some years ago by an Australian professor named Trusswell, a paid consultant for the Australian dairy industry, whose attempt was quickly shot down because it was based on the results of a clinical trial involving rodents that is now utterly discredited. Why? Because the food samples fed to them were contaminated (due to an unexplained error by the Dairy Board which was involved in the trial).
What we often read is material questioning the A2 thesis based on statements by food safety authorities etc in various countries that there is insufficient proof or no convincing proof. The NZFSA has been outrageously guilty of twisting the truth on this, even misrepresenting the results of meta-research which it commissioned for itself. Part of the NZFSA's mandate is to assure overseas markets that NZ's milk exports are safe for human consumption, which it wouldn't be able to do if it admitted knowing there was credible evidence of risks attached to A1 milk. When the head of the European FSA was called in by the government to check on NZFSA's misrepresentation, he was highly critical of it, and did not say the A2 hypothesis was wrong or even "suspect", just that more clinical proof was needed. The food safety authorities say quite rightly that cows milk is an essential nutrient especially for infants and young children, and they just don't want to scare people off drinking it simply because it appears a limited percentage of consumers who are predisposed medically are going to acquire diabetes, CHD or autism from drinking A1 milk.
Someone mentioned a lack of epidemiological evidence. That's incorrect. It was epidemiological data that actually LED TO the identification of A1 as a risk factor for heart disease, diabetes etc in the first place. And it's quite compelling. But epidemiology is not clinical proof of cause and effect, and that's what the scientists are working on now. You need clinical trials, eventually on humans. Which will take time to design, get ethical approval for and run, and you can be sure the industry is not going to kick in funding for them.
My own fear is that ATM will be bought out by the mainstream dairy industry and effectively closed down. But that may be too late, because scientists all round the world are now working on the A1-A2 issue and a lot of farmers are moving to A2-only, so the facts will emerge and the product will carry on even without help from ATM. The mainstream industry must be very worried by the way the scientific evidence is moving.
The current focus on A2 Milk being easier to digest is probably a mere temporary side-issue and a useful short-term profit-earner, based largely on the anecdotal experience of consumers. It is nothing compared to the bigger issue involving the A1 link with heart disease, diabetes, autism and possibly SIDS and other conditions. It is not inconceivable that Big Dairy may eventually face the kind of problems now faced by the tobacco industry which argued successfully for decades that there was "no proof" of a link between smoking and cancer, and is now having to cough up massive damages and admit its product is lethal.
Since then the chart shows a death cross
As punters were happy when the ATM price keeper bouncing off the 200ma (strong support) after a death cross the 200ma (soon to be heading down) becomes resistance implying a sustainable uptrend from here is unlikely for a while
Immediately after the last ATM "death cross" the share price went up from 50c to 96c (+92%). The one prior went from 11c to 68c.